“Second line medications” for supraventricular arrhythmias in children: In‐hospital efficacy and adverse events during treatment initiation of sotalol and flecainide-Reference-Cited by-同舟云学术

“Second line medications” for supraventricular arrhythmias in children: In‐hospital efficacy and adverse events during treatment initiation of sotalol and flecainide

Published:2021-05-16 Issue:8 Volume:32 Page:2207-2215
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:J Cardiovasc Electrophysiol

Author:

Kahr Peter C.¹²^ORCID,Moffett Brady S.³,Miyake Christina Y.¹⁴,Kim Jeffrey J.¹,Valdes Santiago O.¹

Affiliation:

1. Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Texas Children's Hospital Baylor College of Medicine Houston Texas USA

2. Department of Cardiology, University Heart Center University Hospital Zurich Zurich Switzerland

3. Department of Pharmacy Texas Children's Hospital Houston Texas USA

4. Department of Molecular Physiology and Biophysics Baylor College of Medicine Houston Texas USA

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.15077

Reference35 articles.

1. Supraventricular tachycardia in children: Clinical features, response to treatment, and long-term follow-up in 217 patients

2. Paroxysmal tachycardia in infants and children; study of 41 cases;Nadas AS;Pediatrics,1952